- What is Alvit LCS Pharma's primary focus?
- Alvit LCS Pharma is a vertically integrated medical cannabis research and development company specializing in pharmaceutical-grade cannabis product development and drug-delivery technologies.
- What types of products does Alvit LCS Pharma develop?
- Alvit LCS Pharma's products include various types of tablets, sprays, and suppositories, focusing on pharmaceutical-grade cannabis.
- When was Alvit LCS Pharma founded?
- Alvit LCS Pharma was founded in April 2014.
- How many employees does Alvit LCS Pharma have?
- Alvit LCS Pharma has 1-10 employees.
- Has Alvit LCS Pharma participated in any funding rounds?
- Alvit LCS Pharma had a funding round in January 2017 with Oded Zucker as an investor.
- What was a significant corporate development for Alvit LCS Pharma in late 2018?
- In November 2018, Alvit LCS Pharma announced the merger of its cannabis growing activity into Intelicann, a cannabis cultivation facility in Israel that is publicly traded on the Tel Aviv Stock Exchange.
- Who are the co-founders of Alvit LCS Pharma?
- The co-founders of Alvit LCS Pharma are Itschak Lamensdorf, Nachshol Cohen (Co-founder & CSO), and Yoram Sela (Co-founder & VP R&D).
- What is the current stage of Alvit LCS Pharma?
- Alvit LCS Pharma is currently in the Mature stage.